Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
446.88
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
42
43
Next >
Expert Ratings for Vertex Pharmaceuticals
October 24, 2022
Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Analyst Ratings for Vertex Pharmaceuticals
October 24, 2022
Over the past 3 months, 5 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Which Stocks Are Most Likely to Thrive in a Recession? Here's What History Shows
October 23, 2022
Recession-proof stocks must offer something that makes investors want to buy them even when the economy is tanking.
Via
The Motley Fool
2 Powerhouse Stocks That Could Go Parabolic
October 22, 2022
These stocks could take you by surprise.
Via
The Motley Fool
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
October 22, 2022
Procrastination could be problematic with these three bargain stocks.
Via
The Motley Fool
S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength
October 22, 2022
Vertex and LNG play Cheniere Energy are setting up bullishly.
Via
Investor's Business Daily
Vertex Moves Its Alpha-1 Antitrypsin Deficiency Program Forward
October 11, 2022
Via
Benzinga
The Top 5 Stocks Cathie Wood Bought and Sold This Week
October 21, 2022
Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager.
Via
InvestorPlace
These 3 Stocks Are Winning the Bear Market -- Here's How
October 21, 2022
Picking the right markets to compete in makes surviving bear markets much more manageable for these companies.
Via
The Motley Fool
This Beaten-Down ETF Is Still a Screaming Bear-Market Buy
October 21, 2022
Investors wanting to profit from a potential biotech sector bounce should love this exchange-traded fund.
Via
The Motley Fool
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
October 20, 2022
Despite enthusiasm in some camps, the risk of potential cures clouds market projections.
Via
Investor's Business Daily
2 Unstoppable Stocks That Are Beating the Bear Market
October 19, 2022
Is it too late to buy these stocks or are their shares likely to continue rising?
Via
The Motley Fool
2 Top Healthcare Stocks to Buy for the Long Haul
October 18, 2022
These biotech companies have a long ramp of revenue growth ahead.
Via
The Motley Fool
If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today
October 17, 2022
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 9.87% on an annualized basis producing an average annual return of 15.93%. Currently, Vertex Pharmaceuticals...
Via
Benzinga
Kura Oncology Stock Shows Improved Relative Strength; Still Shy Of Benchmark
October 14, 2022
In a welcome move, Kura Oncology stock saw its Relative Strength Rating improve from 69 to 75 on Wednesday.
Via
Investor's Business Daily
My Best Stocks to Buy Now and Hold Forever
October 14, 2022
These are ideal "forever" stocks.
Via
The Motley Fool
3 Red-Hot Stocks That Could Continue to Beat the Market
October 13, 2022
Investors are betting on these companies' revenue growth prospects.
Via
The Motley Fool
The Best Stocks to Invest $5,000 in Right Now
October 13, 2022
These stocks should give investors a big bang for their buck.
Via
The Motley Fool
Amgen Stock Shows Market Leadership With Jump To 90 RS Rating
October 12, 2022
On Wednesday, Amgen stock hit a key technical milestone, with its Relative Strength Rating upgraded to 90, a rise from 78 the day before.
Via
Investor's Business Daily
2 Breakout Growth Stocks to Buy for the Long Haul
October 12, 2022
These unstoppable stocks could be resilient choices to buy and hold in the next bear market and beyond.
Via
The Motley Fool
Is Seagen Stock a Buy Now?
October 12, 2022
It's growing faster than competitors, but headwinds might soon bog it down.
Via
The Motley Fool
The Best Stocks to Invest $50,000 in Right Now
October 12, 2022
These three top stocks are smart buys to consider in the current market and well beyond.
Via
The Motley Fool
Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold
October 12, 2022
Vertex already generates billions in revenue -- but there may be more to come.
Via
The Motley Fool
3 Top Biotech Stocks Defying the Bear Market
October 11, 2022
Bear market, shmear market. These biotech stocks are soaring despite the market downturn.
Via
The Motley Fool
BioCryst Pharmaceuticals Stock Shows Rising Relative Strength
October 10, 2022
On Monday, BioCryst Pharmaceuticals stock received an upgrade to its Relative Strength (RS) Rating, from 90 to 93.
Via
Investor's Business Daily
These 7 Biotech Stocks Are Set to Boom in 2023
October 10, 2022
This article looks at seven biotech stocks that look like good options to move significantly higher in 2023
Via
InvestorPlace
2 Cathie Wood Stocks That Are Beating the Market This Year
October 07, 2022
One is doing much better than the other year to date, but they both have solid prospects ahead.
Via
The Motley Fool
Pacira Pharmaceuticals Stock Shows Rising Relative Strength
October 07, 2022
On Friday, Pacira Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 69 to 73.
Via
Investor's Business Daily
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
October 07, 2022
This quartet of stocks has plenty of growth ahead and is already profitable.
Via
The Motley Fool
3 Stocks Savvy Investors Are Buying Hand Over Fist
October 06, 2022
These high-flying stocks are defying the bear market.
Via
The Motley Fool
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
42
43
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.